- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Electronic nicotine delivery systems did not increase wheezing among adults: JAMA
The use of just electronic nicotine delivery systems (ENDS) was not linked to an increase in the likelihood of self-reported wheeze, says an article published in the Journal of American Medical Association.
The usage of electronic nicotine delivery devices has grown in popularity, raising concerns regarding the effects on respiratory health. It is unknown if the use of ENDS raises the risk of wheezing, which is a typical sign of respiratory disorders. As a result, Luz M. Sánchez-Romero and colleagues undertook this study to present an examination of the longitudinal relationship between ENDS and cigarette usage as well as self-reported wheeze among US adults.
The Population Assessment of Tobacco and Health (PATH) Study from the United States was used. Longitudinal data for adults 18 and older were evaluated from wave 1 (2013-2014) through wave 5 (2018-2019). The data was examined from August 2021 until January 2023. For six tobacco product usage strata, the prevalence of self-reported wheeze (waves 2–5) was assessed. At the following wave, a generalized estimating equations framework assessed the relationship between cigarette and ENDS use and self-reported wheezing. To evaluate the link between joint cigarette and ENDS use categories and the association of ENDS within strata of cigarette use, an interaction term between cigarette and ENDS use was included.
The key findings of this study were;
1. The analytical sample included 17 075 US individuals with an average (SD) age of 45.4 (17) years, with 8922 (51%) females and 10 242 (66%) Non-Hispanic Whites.
2. The largest connection in reporting wheeze was for current cigarette and current ENDS usage, which was equivalent to current cigarette and noncurrent ENDS use and significantly larger than former cigarette and current ENDS use.
3. The odds of self-reported wheezing among never cigarette and current ENDS use were small and not statistically significant when compared to never cigarette and noncurrent ENDS use, and the odds of wheezing and current cigarette and current ENDS use were small and not statistically significant when compared to current cigarette and noncurrent ENDS use.
Using data from a nationally representative cohort research conducted between 2013 and 2019, we discovered that the use of ENDS does not appear to be an independent risk factor for self-reported wheeze. Individuals with a history of cigarette smoking, on the other hand, reported a slight increase in risk between ENDS usage and wheeze. This study contributes to the corpus of literature that examines the possible risks and benefits of ENDS usage in comparison to other tobacco products. These findings can assist guide public health policy recommendations for ENDS usage in various tobacco product user groups.
Reference:
Sánchez-Romero, L. M., Bondarenko, I., Knoll, M., Hirschtick, J. L., Cook, S., Fleischer, N. L., & Levy, D. T. (2023). Assessment of Electronic Nicotine Delivery Systems With Cigarette Use and Self-reported Wheezing in the US Adult Population. In JAMA Network Open (Vol. 6, Issue 4, p. e236247). American Medical Association (AMA). https://doi.org/10.1001/jamanetworkopen.2023.6247
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751